MycoBiotix is commercializing novel therapeutics and medical foods for remodeling of the human gut microbiome, and treatment of dysbiosis and associated disorders. The microbiome, trillions of microorganisms inside us, functions as a vital organ by producing signaling cues critical to health. Imbalances in the microbiome (dysbiosis) are linked to a range of diseases, making it an exciting target for new therapeutics.